Whiting Petroleum Corp. (NYSE:WLL) reported a loss of $353.7 million in its fourth quarter. On a per-share basis, the Denver-based company said it had a loss of $2.68. Earnings, adjusted for one-time gains and costs, came to 44 cents per share. The results did not meet Wall Street expectations. The average estimate of analysts surveyed by Zacks Investment Research was for earnings of 51 cents per share. On Wednesday shares of Whiting Petroleum Corp. (NYSE:WLL) closed at $36.77. Company’s sales growth for last 5 years was 15.20%.
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Cowen 35th Annual Healthcare Conference on March 4 in Boston. Boston Scientific Corporation (NYSE:BSX) in last trading activity moved up 1.81% to close at $16.92. Company weekly performance is 1.44% while its quarterly performance stands at 30.76%. Boston Scientific Corporation (NYSE:BSX) is 1.26% away from its 52 week high.
Hospira, Inc., (NYSE:HSP) has recently announced the launch of Inflectra (infliximab), the first biosimilar monoclonal antibody (mAb), in major European markets. Inflectra is licensed to address several inflammatory conditions such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, adult and pediatric Crohn’s disease, and adult and pediatric ulcerative colitis. On last trading day Hospira Inc. (NYSE:HSP) moved up 0.01% to close at $87.49. Its volatility for the week is 0.14% while volatility for the month is 0.83%. HSP’s sales growth for past 5 years was 2.80% and its EPS growth for past 5 years was -4.60%. Hospira Inc. (NYSE:HSP) monthly performance is 31.56%.
The Babcock & Wilcox Company (NYSE: BWC) reported fourth quarter 2014 revenues of $837.1 million, an increase of $34.3 million, or 4.3%, from the fourth quarter of 2013. GAAP earnings per share for the fourth quarter of 2014 were a loss of $0.97 compared to $1.48 in the fourth quarter of 2013. The Babcock & Wilcox Company (NYSE:BWC) has 6.39% insider ownership while its institutional ownership stands at 94.30%. In last trading activity company’s stock closed at $30.10.
Ixia (NASDAQ: XXIA) reported its preliminary financial results for the fourth quarter and year ended December 31, 2014. Total revenue for the 2014 fourth quarter is expected to be $127.2 million, compared with $120.6 million reported for the 2013 fourth quarter and $114.0 million reported for the 2014 third quarter. On last trading day Ixia (NASDAQ:XXIA) moved up 7.57% to close at $11.09. Its volatility for the week is 3.11% while volatility for the month is 2.52%. XXIA’s sales growth for past 5 years was 21.60% and its EPS growth for past 5 years was 21.30%. Ixia (NASDAQ:XXIA) monthly performance is 9.26%.